Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016

08/02/2021
/ Publications
/
Prostate
Brachytherapy
Gastrointestinal
SBRT
IMPT

Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...

Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.

01/10/2019
/ Publications
/
Prostate
Genitourinary
Anal and rectal cancers
NTCP
Gastrointestinal

This study aimed to assess the applicability of photon-based NTCP models to rectum morbidity outcomes following PT for prostate cancer patients. The data of...

Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center.

11/12/2019
/ Publications
/
Head and neck
Prostate
Patient

A 4-room center treating ~90 patients/day, treating for ~7 years underwent a software upgrade which reduced room and energy switching times from ~30 to~20 sec...

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.

11/08/2019
/ Publications
/
Prostate
Pencil beam scanning
Toxicity
Genitourinary

This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...

MRI-based IMPT planning for prostate cancer.

11/11/2019
/ Publications
/
Prostate
IMPT
Genitourinary

Published in the Green Journal, this study led by MGH aimed to quantify the clinical applicability of converted MR images as a substitute of CT for IMPT...

Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University.

11/08/2019
/ Publications
/
Prostate
Hypofractionation
Genitourinary
Gastrointestinal

A cohort of 146 patients with low-risk prostate cancer were treated to 60 Gy (cobalt Gy equivalent) of proton therapy (20 fractions of 3.0 Gy per fraction) in 4...

A population-based assessment of proton beam therapy utilization in California.

01/02/2020
/ Publications
/
PBT
Brain
Lung
Eye
Breast
Prostate

Based on data from California Cancer Registry, this study reported that of the 2,499,510 people with a cancer diagnosis during the study period, 578,632 (23%)...

Patient Reported Outcomes Following Proton Pencil Beam Scanning vs. Passive Scatter/Uniform Scanning for Localized Prostate Cancer: Secondary Analysis of PCG 001-09.

03/03/2020
/ Publications
/
Prostate
Genitourinary
Passive scattering
Oncology
Pencil beam scanning

This study evaluated PROs with the Expanded Prostate Cancer Index Composite (EPIC) instrument for men with localized PC enrolled in PCG 001-09 (NCT01255748)...

Multivariate normal tissue complication probability models for rectal and bladder morbidity in prostate cancer patients treated with proton therapy

10/10/2020
/ Publications
/
Prostate
Genitourinary
Anal and rectal cancers

The study included rectum and bladder DVHs, 2D rectal dose maps and relevant patient/treatment characteristics from 1151 prostate cancer cases treated with PT...

Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy (PBT) versus Intensity-Modulated Radiotherapy (IMRT) for Prostate Cancer in the Postoperative Setting

10/11/2020
/ Publications
/
Prostate
Genitourinary
PBT
IMRT

This case-matched study analyzed 260 prostate cancer patients including 65 treated with PBT and 195 IMRT. At a median follow-up of 59 months, biochemical...